MedPath

Darusentan

Generic Name
Darusentan
Drug Type
Small Molecule
Chemical Formula
C22H22N2O6
CAS Number
171714-84-4
Unique Ingredient Identifier
33JD57L6RW

Overview

Darusentan is a selective endothelin ETA receptor antagonist. It is being evaluated as a treatment for congestive heart failure and hypertension.

Background

Darusentan is a selective endothelin ETA receptor antagonist. It is being evaluated as a treatment for congestive heart failure and hypertension.

Indication

For the treatment of congestive heart failure and hypertension.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath